SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis

RATIONALE & OBJECTIVE: Recent studies showed that antibody titers after vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the dialysis population are diminished as compared with the general population, suggesting the possible value of a third booster dose. We ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Bensouna, Ilias, Caudwell, Valérie, Kubab, Sabah, Acquaviva, Sandra, Pardon, Agathe, Vittoz, Nathalie, Bozman, Dogan-Firat, Hanafi, Latifa, Faucon, Anne-Laure, Housset, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the National Kidney Foundation, Inc. 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425695/
https://www.ncbi.nlm.nih.gov/pubmed/34508833
http://dx.doi.org/10.1053/j.ajkd.2021.08.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425695/
https://www.ncbi.nlm.nih.gov/pubmed/34508833
http://dx.doi.org/10.1053/j.ajkd.2021.08.005

Ejemplares similares